<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article xml:lang="en" article-type="case-report" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">KJIM</journal-id>
<journal-title-group>
<journal-title>The Korean Journal of Internal Medicine</journal-title></journal-title-group>
<issn pub-type="ppub">1226-3303</issn>
<issn pub-type="epub">2005-6648</issn>
<publisher>
<publisher-name>Korean Association of Internal Medicine</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3904/kjim.1999.14.1.95</article-id>
<article-id pub-id-type="publisher-id">kjim-14-1-95-16</article-id>
<article-categories>
<subj-group>
<subject>Case Report</subject></subj-group></article-categories>
<title-group>
<article-title>Hyperimmunoglobulin E-Recurrent Infection Syndrome In A Patient With Juvenile Dermatomyositis</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Min</surname><given-names>Jun-Ki</given-names></name>
<degrees>M.D.</degrees><xref ref-type="aff" rid="af3-kjim-14-1-95-16"><sup>&#x0002A;</sup></xref><xref ref-type="corresp" rid="c1-kjim-14-1-95-16"/></contrib>
<contrib contrib-type="author">
<name><surname>Cho</surname><given-names>Mi-La</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Seok-Chan</given-names></name>
<degrees>M.D.</degrees></contrib>
<contrib contrib-type="author">
<name><surname>Lee</surname><given-names>Youn-Soo</given-names></name>
<degrees>M.D.</degrees><xref ref-type="aff" rid="af2-kjim-14-1-95-16"><sup>&#x0002A;&#x0002A;</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>Lee</surname><given-names>Sang-Heon</given-names></name>
<degrees>M.D.</degrees></contrib>
<contrib contrib-type="author">
<name><surname>Park</surname><given-names>Sung-Hwan</given-names></name>
<degrees>M.D.</degrees></contrib>
<contrib contrib-type="author">
<name><surname>Hong</surname><given-names>Yeon-Sik</given-names></name>
<degrees>M.D.</degrees></contrib>
<contrib contrib-type="author">
<name><surname>Cho</surname><given-names>Chul-Soo</given-names></name>
<degrees>M.D.</degrees></contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Ho-Youn</given-names></name>
<degrees>M.D.</degrees></contrib></contrib-group>
<aff id="af1-kjim-14-1-95-16">Dept. of Internal Medicine, Division of Rheumatology, Catholic University Medical College, Seoul, Korea</aff>
<aff id="af2-kjim-14-1-95-16">
<label>&#x0002A;&#x0002A;</label>Dept. of Pathology, Kangnam St. Mary&#x02019;s Hospital, Catholic University Medical College, Seoul, Korea</aff>
<aff id="af3-kjim-14-1-95-16">
<label>&#x0002A;</label>Holy Family Hospital, Kangnam St. Mary&#x02019;s Hospital, Catholic University Medical College, Seoul, Korea</aff>
<author-notes>
<corresp id="c1-kjim-14-1-95-16">Address reprint requests to: Jun-Ki Min, M.D., Department of Internal Medicine, Division of Rheumatology, Catholic University Medical College, Holy Family Hospital, Sosa-Dong, Wonmi-Gu, Bucheon-City, &#x00023;2, 420-717, Kyonggi-do, Korea</corresp></author-notes>
<pub-date pub-type="ppub">
<month>1</month>
<year>1999</year></pub-date>
<volume>14</volume>
<issue>1</issue>
<fpage>95</fpage>
<lpage>98</lpage>
<permissions>
<copyright-statement>Copyright &#x000A9; 1999 The Korean Association of Internal Medicine</copyright-statement>
<copyright-year>1999</copyright-year>
<license>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
<abstract>
<p>A 13-year-old girl presented with multiple skin abscesses. She was diagnosed as having juvenile dermatomyositis (DM) at the age of 7 years. She had suffered from recurrent skin infections, atypical pruritic dermatitis and pneumonia since the age of 8 years. Bacteriologic and fungal cultures for skin abscesses and oral mucosa were positive <italic>S. aureus</italic> and C. albicans, respectively. Chemotactic defect in peripheral blood neutrophils was observed. The level of serum IgE was markedly elevated, and anti-S.aureus specific IgE was found. A diagnosis of hyperimmunoglobulin E-recurrent infection syndrome (HIE) was made and she was successfully treated with surgical drainage and antibiotics. To our knowledge, this is the first case report of HIE in a patient with juvenile dermatomyositis.</p></abstract>
<kwd-group>
<kwd>Juvenile dermatomyositis</kwd>
<kwd>hyperimmunoglobulin E-recurrent infection syndrome (HIE)</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Juvenile dermatomyositis (DM) is a multisystem disease characterized by nonsuppurative inflammation of striated muscle, skin and the gastrointestinal tract, and also characterized early in its course by an immune complex vasculitis and, later, the development of calcinosis<sup><xref ref-type="bibr" rid="b1-kjim-14-1-95-16">1</xref>)</sup>. Although the etiology of juvenile DM remains unclear, it is suggested that IgE can be associated with autoimmune diseases, such as systemic lupus erythematosus (SLE) and juvenile DM, by mediating the release of chemical mediators and by faciliating the local deposition of immune complexes<sup><xref ref-type="bibr" rid="b2-kjim-14-1-95-16">2</xref>)</sup>. Intercurrent infections with elevated serum IgE level during the course of the disease give rise to problems in patients with juvenile DM. Atopic dermatitis, or development of calcinosis, may contribute to this problem<sup><xref ref-type="bibr" rid="b3-kjim-14-1-95-16">3</xref>,<xref ref-type="bibr" rid="b4-kjim-14-1-95-16">4</xref>)</sup>. HIE also has the characteristic findings of recurrent infections of the skin and sinopulmonary tract and high serum IgE level. Other findings of HIE include eosinophilia, presence of anti-<italic>S.aureus</italic> specific IgE, defect of neutrophil chemotaxis, poor delayed hypersensitivity responses and eczematoid dermatitis<sup><xref ref-type="bibr" rid="b5-kjim-14-1-95-16">5</xref>)</sup>. Herein, we describe a patient with juvenile DM complicating HIE.</p></sec>
<sec sec-type="cases">
<title>CASE REPORT</title>
<p>A 13-year-old girl was admitted to the hospital because of multiple skin abscesses. Six years before admission, juvenile dermatomyositis was diagnosed at another hospital on the basis of symptoms of proximal muscle weakness, abnormal findings of muscle biopsy, elevated serum muscle enzyme and skin rash on her face. She had not been managed with regular follow-up. There was a history of recurrent skin infections, pneumonia and eczematous dermatitis over the whole body after the diagnosis of juvenile dermatomyositis. She denied any history of allergic diseases. There was no family history of specific diseases. The temperature was 38.0&#x000B0;C, the pulse was 116 and the respirations were 24. The blood pressure was 90/50 mmHg. On physical examination, the skin of her entire body showed multiple hyperpigmented lesions, lichenoid patches and eczemaoid confluent plaques. Oral thrush and subcutaneous cold abscesses of the left upper eye lid, back and right lower quadrant abdomen were found (<xref ref-type="fig" rid="f1-kjim-14-1-95-16">Fig. 1</xref>). No lymphadenopathy was observed. The lungs were clear. Both knee joints had flexion contractures with muscle atrophy. The following laboratory findings were recorded: hemoglobin 10.5gm/dl, white blood cell count 15,000/mm<sup>3</sup> (88,3&#x00025; neutrophils, 6.6&#x00025; lymphocytes, 3.5&#x00025; monocytes, 0.2&#x00025; eosinophils, 1.4&#x00025; basophils), platelet count 288,000/mm<sup>3</sup>, erythrocyte sedimentaion rate 68mm/hour (Westergren method), The protein was 6.7g/dl (albumin 3.2g/dl; globulin 3.5g/dl). The values for glucose, urea nitrogen, creatinine, alanine aminotransferase, aspartate aminotransferase, creatine kinase, lactic dehydrogenase, aldolase, alkaline phosphatase, bilirubin, calcium, phosphorus, sodium, potasium, chloride and magnesium were normal. Urine analysis was normal except for proteinuria(&#x0002B;). Levels of C3, C4 and CH50 were normal. The tests for antinuclear antibody, rheumatoid factor, VDRL, hepatitis surface antigen, hepatitis C virus antibody and C-reactive protein were negative. Antibodies to Sm, RNP, Ro, La, Jo-1 and ds DNA were not detected. Serum immunoglobulin examination revealed normal IgG (1,970 mg/dl; normal 800&#x02013;1,500 mg/dl), IgM (111 mg/dl; normal 45&#x02013;150 mg/dl), elevated IgA (455 mg/dl; normal 90&#x02013;325 mg/dl) and IgE (6,650 mg/dl; normal &lt;200 mg/dl). Follow-up serum IgE levels decreased with the treatment of <italic>S. aureus</italic> infection, but still remained high (3,180 mg/dl, 3,120 mg/dl). Immunoelectrophoresis of serum revealed no evidence of paraproteinemia. Radiographs of the abdomen and both lower extremities showed multiple soft tissue calcifications. EMG and muscle biopsy findings were compatible with inflammatory myopathy (<xref ref-type="fig" rid="f2-kjim-14-1-95-16">Fig. 2</xref>). Antibodies to <italic>S. aureus</italic> of the IgE class were detected by direct ELISA method, as previously described, with some modifications<sup><xref ref-type="bibr" rid="b6-kjim-14-1-95-16">6</xref>)</sup> (<xref ref-type="fig" rid="f3-kjim-14-1-95-16">Fig. 3</xref>). The result of a delayed hypersensitivity skin test to purified protein derivative, tetanus, diphteria, streptococcus, candidia, trichophyton and proteus was negative. Radioallergosorbent tests to common allergens were negative except for Penicillium notatum. Bacteriologic cultures from skin abscesses were positive for <italic>S. aureus</italic>. Cultures from oral mucous lesion grew <italic>Candida albicans</italic>. The total numbers of T cells, T cell subpopulations (CD4&#x0002B;/CD8&#x0002B;) were within normal limits. The Nitroblue-Tetrazolium-test was normal. In vitro lymphocyte proliferation was normal exposure to nonspecific antigens (phytohemagglutinin, phorbol myristate acetate plus ionomycin). The polymorphonuclear leukocyte motility, assessed in a reversible Boyden chamber with fmet-leu-phe and patient&#x02019;s serum as chemo-attractants, as prevoiusly described<sup><xref ref-type="bibr" rid="b5-kjim-14-1-95-16">5</xref>)</sup>, was impaired. She was successfully managed with surgical drainage and antibiotics.</p></sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<p>Some diseases, including chronic granulomatous disease, Wiskott-Aldrich syndrome, icthyosis vulgaris, severe combined immunodeficiency and HIE, have similiar clinical findings of recurrent skin infections<sup><xref ref-type="bibr" rid="b7-kjim-14-1-95-16">7</xref>)</sup>. This patient was diagnosed as having HIE on the basis of recurrent infections of skin and pulmonary, extremely elevated levels of serum IgE and presence of anti-<italic>S.aureus</italic> specific IgE, chemotactic defect of neutrophile, eczematoid dermatitis and normal nitroblue tetrazolium test. The late onset of her recurrent infection and normal eosinophil count were atypical. But these have been observed in other reports<sup><xref ref-type="bibr" rid="b5-kjim-14-1-95-16">5</xref>)</sup>. <italic>S.aureus</italic> and <italic>C.ablicans</italic> were isolated from skin cold abscesses and oral cavity, respectively, in this case. These organisms are known to be most predominant pathogens in recurrent infections of HIE<sup><xref ref-type="bibr" rid="b5-kjim-14-1-95-16">5</xref>)</sup>. <italic>S. aureus</italic> infection with elevated serum IgE is rarely observed in juvenile DM, and this can be partially explained by the previous two reports. First, atopic dermatitis, which is frequently accompanied by <italic>S. aureus</italic>, has a higher tendency for developing juvenile DM<sup><xref ref-type="bibr" rid="b3-kjim-14-1-95-16">3</xref>)</sup>. Second, the development of calcinosis and granulocyte chemotactic defect in juvenile DM is associated with staphylococcal infections<sup><xref ref-type="bibr" rid="b4-kjim-14-1-95-16">4</xref>)</sup>. The causes of recurrent skin infections of <italic>S. aureus</italic> in this patient are presumed to have a somewhat different mechanism from those two. Hochreutener et al suggested that increased <italic>S. aureus</italic> specific IgE level, decreased <italic>S. aureus</italic> specific IgA level, diminished chemotaxis and soft tissue abscesses can be differential points between atopic dermatitis and HIE, but chemotactic defect and anti-<italic>S.aureus</italic> specific IgE were found to be not only HIE but also atopic dermatitis<sup><xref ref-type="bibr" rid="b8-kjim-14-1-95-16">8</xref>,<xref ref-type="bibr" rid="b9-kjim-14-1-95-16">9</xref>)</sup>. So, sometimes, it may be hard to differentiate HIE from atopic dermatitis in a patient with juvenile DM who has elevated IgE level and <italic>S.aureus</italic> infection. Differential diagnosis is important because treatment and prognosis is different. Atopic dermatitis does not have recurrent infections of the sinopulmonary tracts and peculiar cold abscesses and has a dermatitis that differs in character and distribution from lesions of HIE<sup><xref ref-type="bibr" rid="b5-kjim-14-1-95-16">5</xref>)</sup>. This patient denied any history of allergy, and RAST(radioallergosorbent test) to common allergens, except for Penicillium notatum, were negative. Moore et al emphasized the relationship between the development of calcinosis and recurrent staphylococcal infections with raised IgE in juvenile DM<sup><xref ref-type="bibr" rid="b4-kjim-14-1-95-16">4</xref>)</sup>. Although the level of serum IgE in Moore&#x02019;s cases are elevated, most of them do not meet the definition of HIE (&#x02265;2,000 IU/ml). But this patient had extremely elevated IgE level (6,600 IU/ml) during infection and had constantly raised serum IgE levels(&#x02265;3,000 IU/ml) during follow-up. Anti-<italic>S.aureus</italic> specific IgE was detected only during <italic>S. aureus</italic> infection in this case. Calcinosis occurs commonly with scleroderma, as well as dermatomyositis, and rarely in association with SLE<sup><xref ref-type="bibr" rid="b10-kjim-14-1-95-16">10</xref>)</sup>. HIE has been rarely reported in patients with SLE<sup><xref ref-type="bibr" rid="b11-kjim-14-1-95-16">11</xref>&#x02013;<xref ref-type="bibr" rid="b13-kjim-14-1-95-16">13</xref>)</sup>, but these cases had no association with calcinosis. Calcinosis develops in up to half the patients with juvenile dermatomyositis<sup><xref ref-type="bibr" rid="b1-kjim-14-1-95-16">1</xref>)</sup>. It must be clarified whether recurrent skin infection with elevated IgE occurs in most juvenile DM patients with calcinosis or not. Although the immunologic basis of elevated serum IgE in patients with HIE has not been defined, a deficiency of suppressor T cell to inhibit IgE production<sup><xref ref-type="bibr" rid="b5-kjim-14-1-95-16">5</xref>)</sup>, imbalances between IL-4 producing and IFN-&#x003B3; producing helper T cells<sup><xref ref-type="bibr" rid="b14-kjim-14-1-95-16">14</xref>)</sup> and decreased metabolism of IgE<sup><xref ref-type="bibr" rid="b15-kjim-14-1-95-16">15</xref>)</sup> seem to be responsible for elevated levels of IgE. There were reports that CD8&#x0002B; to CD4&#x0002B; ratio was reduced in a patient with juvenile DM<sup><xref ref-type="bibr" rid="b16-kjim-14-1-95-16">16</xref>)</sup>. But this was not found in our case. The causes of susceptibility to infections have not been documented. Schopfer et al suggest that histamine is released on crosslinkng of mast cell-bound antistaphylococcal IgE by staphylococcal antigens and interferes with the activity of polymorphonuclear leukocytes, resulting in the failure of effective <italic>S. aureus</italic> clearing<sup><xref ref-type="bibr" rid="b17-kjim-14-1-95-16">17</xref>)</sup>. It is known that there is variability in both HIE and juvenile DM patient&#x02019;s neutrophil and monocyte chemotaxis<sup><xref ref-type="bibr" rid="b5-kjim-14-1-95-16">5</xref>)</sup>. Whether the neutrophils were intrinsically abnormal or not was inconclusive in a patient with HIE, but chemotactic defect of neutrophil to fmet-leu-phe and patient&#x02019;s serum as chemo-attractants was observed in this case. HIE has significantly lower proportions of circulating T cells that can produce IFN-&#x003B3; and TNF-&#x003B1;, in comparison with normal controls, which also may contribute to recurrent infections<sup><xref ref-type="bibr" rid="b14-kjim-14-1-95-16">14</xref>)</sup>. In conclusion, similar findings, including elevated serum IgE, arti-<italic>S.aureus</italic> IgE and chemotactic defect of neutrophil, can be found in patients with HIE, juvenile DM and atopic dermatitis. HIE must be considered in the differential diagnosis of a patient with juvenile DM who has an elevated level of IgE and staphylococcus aureus skin infection. It will be interesting to define whether the underlying mechanism is the same or not in these diseases.</p></sec></body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="b1-kjim-14-1-95-16"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansell</surname><given-names>BM</given-names></name></person-group><article-title>Juvenile dermatomyositis</article-title><source>Rheum Dis Clin North Am</source><volume>17</volume><fpage>931</fpage><lpage>942</lpage><year>1991</year></mixed-citation></ref>
<ref id="b2-kjim-14-1-95-16"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cochrane</surname><given-names>CG</given-names></name><name><surname>Koffler</surname><given-names>D</given-names></name></person-group><article-title>Immune complex disease in experimental animals and man</article-title><source>Adv Immunol</source><volume>16</volume><fpage>185</fpage><lpage>264</lpage><year>1973</year></mixed-citation></ref>
<ref id="b3-kjim-14-1-95-16"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishida</surname><given-names>T</given-names></name><name><surname>Ohashi</surname><given-names>M</given-names></name><name><surname>Matsumoto</surname><given-names>Y</given-names></name><name><surname>Morikawa</surname><given-names>J</given-names></name><name><surname>Sasaki</surname><given-names>R</given-names></name></person-group><article-title>Connection of atopic disease in Japanese patients with juvenile dermatomyositis based on serum IgE levels</article-title><source>Clinical Rheumatol</source><volume>12</volume><fpage>41</fpage><lpage>48</lpage><year>1993</year></mixed-citation></ref>
<ref id="b4-kjim-14-1-95-16"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>EC</given-names></name><name><surname>Cohen</surname><given-names>F</given-names></name><name><surname>Douglas</surname><given-names>SD</given-names></name><name><surname>Gutta</surname><given-names>V</given-names></name></person-group><article-title>Staphylococcal infections in childhood dermatomyositis-association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect</article-title><source>Ann Rheum Dis</source><volume>51</volume><fpage>378</fpage><lpage>383</lpage><year>1992</year></mixed-citation></ref>
<ref id="b5-kjim-14-1-95-16"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donabedian</surname><given-names>H</given-names></name><name><surname>Gallin</surname><given-names>JI</given-names></name></person-group><article-title>The hyperimmunoglobulin E recurrent-infection (Job&#x02019;s) syndrome: A review of the NIH experience and the literature</article-title><source>Medicine</source><volume>62</volume><fpage>195</fpage><lpage>208</lpage><year>1983</year></mixed-citation></ref>
<ref id="b6-kjim-14-1-95-16"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dreskin</surname><given-names>SC</given-names></name><name><surname>Goldsmith</surname><given-names>PK</given-names></name><name><surname>Gallin</surname><given-names>JI</given-names></name></person-group><article-title>Immunoglobulins in the hyperimmunoglobulin E and recurrent infection(Job&#x02019;s) syndrome: Deficiency of anti-staphylococcus aureus Immunoglobulin A</article-title><source>J Clin invest</source><volume>75</volume><fpage>26</fpage><lpage>34</lpage><year>1985</year></mixed-citation></ref>
<ref id="b7-kjim-14-1-95-16"><label>7.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Holland</surname><given-names>SM</given-names></name><name><surname>Gallin</surname><given-names>JI</given-names></name></person-group><article-title>Evaluation of the patient with suspected immunodeficiency</article-title><person-group person-group-type="editor"><name><surname>Mandell</surname><given-names>GL</given-names></name><name><surname>Bennet</surname><given-names>JE</given-names></name></person-group><source>Principles and practice of infectious diseases</source><edition>4th ed</edition><publisher-loc>New York</publisher-loc><publisher-name>Chuchill Livingstone</publisher-name><fpage>149</fpage><lpage>158</lpage><year>1995</year></mixed-citation></ref>
<ref id="b8-kjim-14-1-95-16"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochreutener</surname><given-names>H</given-names></name><name><surname>Wuthrich</surname><given-names>B</given-names></name><name><surname>Huwyler</surname><given-names>T</given-names></name><name><surname>Schopfer</surname><given-names>K</given-names></name><name><surname>Baerlocher</surname><given-names>K</given-names></name></person-group><article-title>Variant of Hyper-IgE syndrome: The differentiation from atopic dermatitis is important because of treatment and prognosis</article-title><source>Dermatologica</source><volume>182</volume><fpage>7</fpage><lpage>11</lpage><year>1991</year></mixed-citation></ref>
<ref id="b9-kjim-14-1-95-16"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motala</surname><given-names>C</given-names></name><name><surname>Potter</surname><given-names>PC</given-names></name><name><surname>Weinberg</surname><given-names>EG</given-names></name><name><surname>Malherbe</surname><given-names>D</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name></person-group><article-title>Anti-staphylococcus aureus-specific IgE in atopic dermatitis</article-title><source>J Allergy Clin Immunol</source><volume>78</volume><fpage>583</fpage><lpage>589</lpage><year>1986</year></mixed-citation></ref>
<ref id="b10-kjim-14-1-95-16"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cousins</surname><given-names>MAM</given-names></name><name><surname>Jones</surname><given-names>DB</given-names></name><name><surname>Whyte</surname><given-names>MP</given-names></name><name><surname>Monafo</surname><given-names>WW</given-names></name></person-group><article-title>Surgical management of calcinosis cutis universalis in systemic lupus erythematosus</article-title><source>Arthritis Rheum</source><volume>40</volume><fpage>570</fpage><lpage>572</lpage><year>1997</year></mixed-citation></ref>
<ref id="b11-kjim-14-1-95-16"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schopfer</surname><given-names>K</given-names></name><name><surname>Feldges</surname><given-names>A</given-names></name><name><surname>Baerlocher</surname><given-names>K</given-names></name><name><surname>Parisot</surname><given-names>RF</given-names></name><name><surname>Wilhelm</surname><given-names>JA</given-names></name><name><surname>Matter</surname><given-names>L</given-names></name></person-group><article-title>Systemic lupus erythematosus in Staphylococcus aureus hyperimmunog lobulinemia E syndrome</article-title><source>Br Med J</source><volume>287</volume><fpage>524</fpage><lpage>526</lpage><year>1983</year></mixed-citation></ref>
<ref id="b12-kjim-14-1-95-16"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leyh</surname><given-names>F</given-names></name><name><surname>Wendt</surname><given-names>V</given-names></name><name><surname>Scherer</surname><given-names>R</given-names></name></person-group><article-title>Systemic lupus erythematosus and hyperimmunoglobulinemia E syndrome in a 13-year-old girl</article-title><source>Z Hautkr</source><volume>61</volume><fpage>611</fpage><lpage>614</lpage><year>1985</year></mixed-citation></ref>
<ref id="b13-kjim-14-1-95-16"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>North</surname><given-names>J</given-names></name><name><surname>Kotecha</surname><given-names>S</given-names></name><name><surname>Houtman</surname><given-names>P</given-names></name><name><surname>Whaley</surname><given-names>K</given-names></name></person-group><article-title>Systemic lupus erythematosus complicating hyper IgE syndrome</article-title><source>Br J Rheumatol</source><volume>36</volume><fpage>297</fpage><lpage>298</lpage><year>1997</year></mixed-citation></ref>
<ref id="b14-kjim-14-1-95-16"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romagnani</surname><given-names>S</given-names></name></person-group><article-title>Regulation and deregulation of human IgE synthesis</article-title><source>Immunol Today</source><volume>11</volume><fpage>316</fpage><lpage>321</lpage><year>1990</year></mixed-citation></ref>
<ref id="b15-kjim-14-1-95-16"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dreskin</surname><given-names>SC</given-names></name><name><surname>Goldsmith</surname><given-names>PK</given-names></name><name><surname>Strober</surname><given-names>W</given-names></name><name><surname>Zech</surname><given-names>LA</given-names></name><name><surname>Gallin</surname><given-names>JI</given-names></name></person-group><article-title>Metabolism of immunoglobulin E in patients with markedly elevated serum immunoglobulin E levels</article-title><source>J Clin Invest</source><volume>79</volume><fpage>1764</fpage><lpage>1772</lpage><year>1987</year></mixed-citation></ref>
<ref id="b16-kjim-14-1-95-16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Gorman</surname><given-names>MR</given-names></name><name><surname>Corrochano</surname><given-names>V</given-names></name><name><surname>Roleck</surname><given-names>J</given-names></name><name><surname>Donovan</surname><given-names>M</given-names></name><name><surname>Packman</surname><given-names>LM</given-names></name></person-group><article-title>Flow cytometric analyses of the lymphocyte subsets in peripheral blood of children with untreated active juvenile dermatomyositis</article-title><source>Clin Diagn Lab Immunol</source><volume>2</volume><fpage>205</fpage><lpage>208</lpage><year>1995</year></mixed-citation></ref>
<ref id="b17-kjim-14-1-95-16"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schopfer</surname><given-names>K</given-names></name><name><surname>Baerlocher</surname><given-names>K</given-names></name><name><surname>Price</surname><given-names>P</given-names></name><name><surname>Krech</surname><given-names>U</given-names></name><name><surname>Quie</surname><given-names>PG</given-names></name><name><surname>Douglas</surname><given-names>SD</given-names></name></person-group><article-title>Staphylococcal IgE antibodies, hyperimmunoglobuliemia E and staphylococcus aureus infections</article-title><source>N Engl J Med</source><volume>300</volume><fpage>835</fpage><lpage>838</lpage><year>1979</year></mixed-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures</title>
<fig id="f1-kjim-14-1-95-16">
<label>Fig. 1.</label>
<caption>
<p>Cold abscess in left upper eye-lid. <italic>S.aureus</italic> was isolated by bacterial culture.</p></caption>
<graphic xlink:href="kjim-14-1-95-16f1.tif"/></fig>
<fig id="f2-kjim-14-1-95-16">
<label>Fig. 2.</label>
<caption>
<p>Muscle biopsy specimen showed various-sized muscle fibers and moderately increased adipose tissue due to extensive necrosis and degeneration of muscle fibers (&#x000D7; 100).</p></caption>
<graphic xlink:href="kjim-14-1-95-16f2.tif"/></fig>
<fig id="f3-kjim-14-1-95-16">
<label>Fig. 3.</label>
<caption>
<p>IgE binding to S. aureus. Anti-<italic>S. aureus</italic> specific serum IgE was measured with <italic>S. aureus</italic> Wood 46 strain (Sigma) in our patient (P), five patients with bronchial asthma (A) and three bacteremic patients with <italic>S. aureus</italic> (S) by direct ELISA as Dreskin&#x02019;s method with some modifications. All samples were assayed in duplicate.</p></caption>
<graphic xlink:href="kjim-14-1-95-16f3.tif"/></fig></sec></back></article>
